pharma · Acute Cannabinoid Intoxication · ANEB
Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a pharma organization headquartered in Austin, USA. It trades on NYSE under ticker ANEB. Primary therapeutic focus areas include Acute Cannabinoid Intoxication. NovaPharmaNews links 2 clinical
Austin, USA HQ
10 Employees
Public company Type
ANEB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Austin, USA
- Employees
- 10
- Programs
- 2
- Drugs
- 0
- Patents
- 1
selonabant
Phase 1 · small molecule · Healthy Volunteers
selonabant for Healthy Volunteers is a Phase 1 program (small_molecule) at Anebulo Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code AN-IV-25-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Anebulo Pharmaceuticals
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Healthy Volunteers
- Status
- completed
- Trials
- 1